Sino Biopharmaceutical

Sino Biopharmaceutical

World Rank (Aug-2026)
1827
Market Cap (Aug-2026)
12.683 Billion USD
World Rank (Jan-05-2024)
2,021
Market Cap (Jan-05-2024)
7.944 Billion USD
World Rank (Jul-30-2023)
1,899
Market Cap (Jul-30-2023)
8.629 Billion USD
World Rank (Jan-07-2022)
1,423
Market Cap (Jan-07-2022)
14.151 Billion USD
World Rank (Jan-01-2021)
999
Market Cap (Jan-01-2021)
18.245 Billion USD
Headquarters Country
Hong Kong
Employee Count
26,272
Employee Count as of Date
As on 2023
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
4,612 Million USD
Annual Operating Income in USD
1,000 Million USD
Annual Net Income in USD
339 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
11,011 Million USD
Total Liabilities in USD
4,914 Million USD
Total Equity in USD
6,097 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biopharmaceutical
Biotechnology
HealthCare Products
Pharmaceutical
Company Website
SINO BIOPHARM - Bio-Pharmaceutical Company
Wikipedia
Wikipedia
Yahoo
Yahoo @ HongKong
Company Profile
SINO BIOPHARMACEUTICAL is BioPharmaceutical company with headquarters is in Hong Kong. The products include a variety of biological drugs and chemical drugs, and are in an advantageous position in many potential therapeutic fields such as liver disease, tumor, cardiovascular and cerebrovascular disease, orthopedics, digestive system, anti-infection and respiratory diseases.
Founded Year
2000
Stock Exchange
HKeX

Share